LianBio (LIANY) Executive Compensation
LianBio (LIANY) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LIANY
CIK: 1831283
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerGregory Brunner
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SC 13G | 2024-11-14 | — | SC 13G Filing | 0001214659-24-019189 | View SEC Doc Filr Page |
| 4 | 2024-04-11 | 2024-01-02 | FORM 4 | 0001990498-24-000005 | View SEC Doc Filr Page |
| 15-12G | 2024-03-21 | — | 15-12G | 0001628280-24-012377 | View SEC Doc Filr Page |
| EFFECT | 2024-03-12 | — | EFFECT Filing | 9999999995-24-000645 | View SEC Doc Filr Page |
| F-6 POS | 2024-03-12 | — | F-6 POS Filing | 0001193805-24-000357 | View SEC Doc Filr Page |
| S-8 POS | 2024-03-12 | — | S-8 POS | 0001628280-24-010381 | View SEC Doc Filr Page |
| S-8 POS | 2024-03-12 | — | S-8 POS | 0001628280-24-010380 | View SEC Doc Filr Page |
| S-8 POS | 2024-03-12 | — | S-8 POS | 0001628280-24-010379 | View SEC Doc Filr Page |
| POS AM | 2024-03-12 | — | POS AM | 0001628280-24-010378 | View SEC Doc Filr Page |
| 25 | 2024-03-11 | — | 25 | 0001628280-24-010146 | View SEC Doc Filr Page |
| SC 13D/A | 2024-02-29 | — | SC 13D/A | 0001193125-24-053902 | View SEC Doc Filr Page |
| 4 | 2024-02-20 | 2024-02-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-003733 | View SEC Doc Filr Page |
| 4 | 2024-02-20 | 2024-02-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-003732 | View SEC Doc Filr Page |
| 4 | 2024-02-20 | 2024-02-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-003729 | View SEC Doc Filr Page |
| 4 | 2024-02-20 | 2024-02-15 | FORM 4 | 0001831283-24-000011 | View SEC Doc Filr Page |
| 4 | 2024-02-20 | 2024-02-15 | FORM 4 | 0001831283-24-000010 | View SEC Doc Filr Page |
| 8-K | 2024-02-13 | 2024-02-09 | 8-K | 0001831283-24-000004 | View SEC Doc Filr Page |
| 144 | 2024-01-08 | — | 144 Filing | 0001973379-24-000004 | View SEC Doc Filr Page |
| 144 | 2023-12-29 | — | 144 Filing | 0001973379-23-000260 | View SEC Doc Filr Page |
| 3 | 2023-12-26 | 2023-12-19 | FORM 3 | 0001990498-23-000004 | View SEC Doc Filr Page |
| 8-K | 2023-12-26 | 2023-12-22 | 8-K | 0001831283-23-000145 | View SEC Doc Filr Page |
| 8-K | 2023-12-20 | 2023-12-19 | 8-K | 0001831283-23-000141 | View SEC Doc Filr Page |
| 8-K | 2023-12-19 | 2023-12-16 | 8-K | 0001831283-23-000137 | View SEC Doc Filr Page |
| 8-K | 2023-12-06 | 2023-12-06 | 8-K | 0001831283-23-000133 | View SEC Doc Filr Page |
| 8-K | 2023-12-01 | 2023-11-30 | 8-K | 0001831283-23-000129 | View SEC Doc Filr Page |